Advanced Aseptic & Lyo Technologies, GMP Manufacturing & Packaging

Advanced Aseptic & Lyo Technologies, GMP Manufacturing & Packaging
Product Description

As a GMP-certified CDMO, we offer end-to-end solutions tailored to the needs of the pharmaceutical and nuclear medicine industries. Our expertise extends the entire development and production lifecycle, with highest quality and compliance standards.

- Liquid & Lyophilized Products – Scalable batch production from 1 to 300 liters- Sterile Small-Volume Manufacturing – cGMP-compliant production for clinical trials and R&DAPI Synthesis – Small molecule 
- API synthesis 
- Drug Product Development – QbD-driven formulation, process development, validation, and scale-up for liquid and lyophilized injections
- All-Isotope License – Including α-Emitters, supporting a broad range of nuclear medicine applications
- Comprehensive Tech Transfer & Validation –  microbiological, analytical, radioanalytical controls, & stability testing

Read more Show less

Medi-Radiopharma

  • Country/Region:
    Hungary
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Laboratory Services
View company profile
Categories
more categories Show less
Specifications
  • Model
    Custom
More specifications Fewer specifications

Medi-Radiopharma

  • Country/Region:
    Hungary
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Laboratory Services
View company profile

Medi-Radiopharma resources (1)

  • MRP's New fill-finish facility in Budapest, Hungary

    Video MRP's New fill-finish facility in Budapest, Hungary

    In 2025, Medi-Radiopharma expands its capabilities with a state-of-the-art 6,000 m² GMP facility, boosting our annual capacity by 1.2 million vials. The site features advanced aseptic fill-finish lines, lyophilization technologies, in-house microbiology labs, and integrated packaging solutions. This investment strengthens our position as a trusted CDMO partner, delivering scalable, high-quality sterile manufacturing for innovative therapies worldwide.
    2025-09-03